##plugins.themes.academic_pro.article.sidebar##

Download
pdf

##plugins.themes.academic_pro.article.main##

Abstract

The current study aimed to find the effective role of S. officinale root extract against the hepatotoxicity of Orlistat in male rats. The University of Kirkuk's College of Science is where the current study was carried out. 24 mature male rats were purchased from an Iraqi care facility and a pharmaceutical research facility in Baghdad. They ranged in age from 12 to 16 weeks, and their average body weight was 175 to 200 g. The animals were kept in sanitary conditions, were clinically healthy, and were housed in metal cages and glass bottles. Throughout the duration of the trial, food and water were freely available. 24 male albino rats were placed into four groups, each with six rats: Negative group: which received orally normal saline (0.5) ml/kg BW. Positive group: which received orally Orlistat 2 ml/kg BW. Extract group: which received orally S. officinale 150mg/kg BW. Treated group: which received orally Orlistat 2 ml/kg and treated by S. officinale 150mg/kg. About the results of Orlistat administration, the liver showed hypertrophy of certain areas of hepatocytes, congestion and hemorrhage noticed in certain places, hepatocyte degeneration was linked with auxes of nuclei, ambiguous nuclei, karyolysis of nuclei, and fibrosis. Aggregation of lymphocytes was evident in some areas and had a nodular appearance. After administration of Orlistat to induced various liesions in liver and treated with S. officinale root extract, The liver's cross sections revealed a semi-normal structure, a normal central vein, a semi-normal organization of hepatocytes around the vein, and sinusoids with the same width as those in the control group

Keywords

Symphytum officinale Orlistat hepatotoxicity effect

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Zainab Hasan Majeed. (2023). Estimate the role of Symphytum officinale root extract against the hepatotoxicity effect of Orlistat in male rats. Texas Journal of Agriculture and Biological Sciences, 14, 112–119. Retrieved from https://zienjournals.com/index.php/tjabs/article/view/3608

References

  1. Schmelzer, G.; Gurib-Fakim, A. Plant Resources of Tropical Africa: Medicinal plants 1; Backhuys Publishers CTA: Netherlands, 2008.
  2. Horinouchi, C.D.; Otuki, M.F. Botanical briefs: comfrey (Symphytum officinale). Cutis 2013, 91, 225–228.
  3. Frost, R.; MacPherson, H.; O'Meara, S.M. A critical scoping review of external uses of comfrey (Symphytum spp.). Complementary Ther. Med. 2013, 21, 724–745,
  4. Staiger, C. Comfrey: A clinical overview. Phytother. Res. 2012, 26, 1441–1448,
  5. Riet-Correa, F.; Medeiros, R.; Tokarnia, C.; Dobereiner, J. Toxic plants for livestock in Brazil: Economic impact, toxic species, control measures and public health implications. In Poisonous Plants: Global Research and Solutions; Panter, K.E., Wierenga, T.L., Pfister, J.A., Eds.; CABI Press: Wallingford, UK, 2007; pp. 2–14.
  6. Dennis R, Dezelak C, Grime J. 1987. Studies on Symphytum species – HPLC determination of allantoin. Acta Pharm Hung 57: 267–274.
  7. Franz G. 1969. Untersuchungen über die Schleimpolysaccharide von Tussilago farfara L., Symphytum officinalis L., Borago officinalis L. und Viola tricolor L. Planta Med 17: 217–220
  8. Andres RMP. 1991. Klinische und instrumentalanalytische Untersuchung von Dermatika mit Extrakten aus Symphytum officinale L. Dissertation, University of Bern.
  9. Grabias B, Swiatek L. 1998. Phenolic acids in Symphytum officinale L. Pharm Pharmacol Lett 8: 81–83.
  10. Teuscher E, Willuhn G, Loew D. 2009. Symphyti radix – Beinwellwurzel. In Teedrogen und Phytopharmaka. Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage, 5th edn, Wichtl M (ed). Wissenschaftliche Verlagsgesellschaft: Stuttgart; 644–646
  11. Hiermann A, Writzel M. 1998. Antiphlogistic glycopeptide from the roots of Symphytum officinale. Pharm Pharmacol Lett 8: 154–157.
  12. Aftab K, Shaheen F, Mohammad FV, Noorwala M, Ahmad VU. 1996. Phyto-pharmacology of saponins from Symphytum officinale L. Adv Exp Med Biol 404: 429–442.
  13. Wagner H, Hörhammer L, Frank U. 1970. Lithospermsäure, das antihormonale Wirkprinzip von Lycopus europaeus L. (Wolfsfuß) und Symphytum officinale L. (Beinwell). 3. Mitteilung: Über die Inhaltsstoffe von Arzneipflanzen mit hormon- und antihormonähnlicher Wirkung. Arzneim-Forsch Drug Res 20: 705–713.
  14. Sowa, I., Paduch, R., Strzemski, M., Zielińska, S., Rydzik-Strzemska, E., Sawicki, J., ... & Wójciak-Kosior, M. (2018). Proliferative and antioxidant activity of Symphytum officinale root extract. Natural product research, 32(5), 605-609.
  15. Sharifi-Rad, J.; Sharifi-Rad, M.; Salehi, B.; Iriti, M.; Roointan, A.; Mnayer, D.; Soltani-Nejad, A.; Afshari, A. In vitro and in vivo assessment of free radical scavenging and antioxidant activities of Veronica persica Poir. Cell. Mol. Biol. (Noisy-Le-GrandFr. ) 2018, 64, 57–64.
  16. Ahmed Hasan S, Fakhraddin Raheem T, Mohammed Abdulla H. Phenotypic, Antibiotyping, and Molecular Detection of Klebsiella Pneumoniae Isolates from Clinical Specimens in Kirkuk, Iraq. Arch Razi Inst. 2021; 76(4):1061-7.
  17. Hasan SA, Abass KS. Prevalence of Gram Negative Bacteria Isolated from Patients with Burn Infection and their Antimicrobial Susceptibility Patterns in Kirkuk City, Iraq. Indian J Public Health Res Dev. 2019;10(8):2197. [DOI:10.5958/0976 5506.2019.02184.3]
  18. Ahmed Hasan S, Mohammed Bakr M. Bacteriological and Molecular Detection of Klebsiella oxytoca and its Resistance to Antibiotics among Clinical Specimens from Kirkuk, Iraq. Arch Razi Inst. 2022;77(5):1521-5.
  19. Ahmed Hasan S, Saleh I, Ali H. Bacteriological and Molecular Detection of Staphylococcus Aureus and its Resistance to Methicillin among Specimens from Kirkuk Community. Ann Rom Soc Cell Biol. 2021;25(7):461-73.
  20. Fakhraddin Raheem T, Ahmed Hasan Ali S. Prevalence and Multi-Drug Resistance Patterns of Uropathogenic E.coli isolated from Women Patients in Kirkuk city, Iraq. Iran J Med Microbiol. 2022; 16 (6):609-14. [10.30699/ijmm.16.6.609]
  21. Ahmed Hasan S, Raoof WM, Kamal Rachid S. A Systematic Review: The Current Status of Carbapenem Resistance In Iraq. World Bull Public Health. 2022;13:88-94.
  22. Ahmed Hasan S. Pseudomonas aeruginosa and the multifactorial antibiotic resistance. Eurasian Med Res Periodical. 2022;11:85-94.
  23. Hasan SA, Najati AM, Abass KS. Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq. Eurasia J Biosci. 2019;13(2):1045-50.
  24. Hasan SA, Najati AM, Abass KS. Prevalence and antibiotic resistance of “pseudomonas aeruginosa” isolated from clinical samples in Kirkuk City, Iraq. Eurasia J Biosci. 2020;14(1):1821-5.
  25. Koll, R.; Buhr, M.; Dieter, R.; Pabst, H.; Predel, H.-G.; Petrowicz, O.; Giannetti, B.; Klingenburg, S.; Staiger, C. Efficacy and tolerance of a comfrey root extract (Extr. Rad. Symphyti) in the treatment of ankle distorsions: results of a multicenter, randomized, placebo-controlled, double-blind study. Phytomedicine 2004, 11, 470–477.
  26. Saul, Stephanie (7 February 2007). "Weight-Loss Drug to Be Sold Over the Counter". The New York Times. Retrieved 10 February 2007.
  27. GlaxoSmithKline receives European Commission approval to market alli (orlistat 60mg). GlaxoSmithKline. 21 January 2009. Retrieved 22 January 2009
  28. Anderson JW. Orlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage. Expert opinion on pharmacotherapy. 2007;8(11):1733-42.
  29. Kanaya AM. Review: orlistat, sibutramine, and rimonabant reduce weight in overweight and obese persons. ACP journal club. 2008;148(2):50.
  30. Morris M, Lane P, Lee K, Parks D. An integrated analysis of liver safety data from orlistat clinical trials. Obesity facts. 2012;5(4):485-94.
  31. Douglas IJ, Langham J, Bhaskaran K, Brauer R, Smeeth L. Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink. Bmj-Brit Med J. 2013;346.
  32. Saleh, A.H. (2019). Potential effect of green zinc oxide nanoparticles in treatment of kidney lesions that induced by Burkholderia mallei in albino male rats. Biochem. Cel. Arch. 19: 2439–2443.
  33. Sari A. Nephrotoxic Effects of Drugs. Poisoning Mod. World New Tricks Old Dog. 2019:24.
  34. Chandel, S. (2014). Role of Symphytum Officinale As An Osteoinducer In Long Bone Fracture Repair In Canine (Doctoral dissertation, MAFSU).
  35. Matcovschi, C.; Calistru, Z.; Cojocaru, M.; Vaˆlcu, S. Symphytum officinale (L) gaertn — A prospective hepatoprotective and hepatoregenerative plant. Pharmacol. Res. 1995, 31, 91.
  36. Trifan, A.; Opitz, S.E.W.; Josuran, R.; Grubelnik, A.; Esslinger, N.; Peter, S.; Bräm, S.; Meier, N.; Wolfram, E. Is comfrey root more than toxic pyrrolizidine alkaloids? Salvianolic acids among antioxidant polyphenols in comfrey (Symphytum officinale L.) roots. Food Chem. Toxicol. 2018, 112, 178–187.
  37. Smith, D.B.; Jacobson, B.H. Effect of a blend of comfrey root extract (Symphytum officinale L.) and tannic acid creams in the treatment of osteoarthritis of the knee: randomized, placebo-controlled, double-blind, multiclinical trials. J. Chiropr. Med. 2011, 10, 147–156.
  38. NEAGU, E.; PĂUN, G.; RADU, L.G. Phytochemical study of some Symphytum officinalis extracts concentrated by membranous procedures. Sci. Bull. -Univ. Politeh. Buchacharest 2011, 3-7.
  39. Neagu, E.; Paun, G.; Radu, G. Antioxidant capacity of some Symphytum officinalis extracts processed by ultrafiltration. Rom. Biotechnol. Lett. 2010, 15, 5505–5511.